Discover
PCVX
Vaxcyte, Inc.
56.08
2 x 41.43
2 x 70.95
bid
ask
-
2.05
3.53%
2 @ 04:00 PM
57.00 +0.92 (1.64%)
| Ytd | 21.54% | |
| 1y | 70.25% |
55.39
day range
58.29
29.08
52 week range
65.00
| Open | 57.82 | Prev Close | 58.13 | Low | 55.39 | High | 58.29 | Mkt Cap | 8.10B |
| Vol | 1.47M | Avg Vol | 1.60M | EPS | -6.89 | P/E | N/A | Forward P/E | -7.83 |
| Beta | 1.24 | Short Ratio | 9.75 | Inst. Own | 114.63% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 52.64 | 200-d Avg | 49.96 | 1yr Est | 109.00 |
| Income Statement | |||
| Operating Expenses | 345.85M | ||
| Research and Development Expense | 312.78M | ||
| Selling, General and Administrative Expense | 33.07M | ||
| Operating Income | -345.85M | ||
| Net Income | -320.62M | ||
| Net Income Common Stock | -320.62M | ||
| Net Income Common Stock (USD) | -320.62M | ||
| Consolidated Income | -320.62M | ||
| Earnings per Basic Share | -2.30 | ||
| Earnings per Basic Share (USD) | -2.30 | ||
| Earnings per Diluted Share | -2.30 | ||
| Earning Before Interest & Taxes (EBIT) | -320.62M | ||
| Earning Before Interest & Taxes (USD) | -320.62M | ||
| Weighted Average Shares | 139.51M | ||
| Weighted Average Shares Diluted | 139.51M | ||
| Balance Sheet | |||
| Cash and Equivalents | 260.84M | ||
| Cash and Equivalents (USD) | 260.84M | ||
| Investments | 2.48B | ||
| Investments Current | 1.48B | ||
| Investments Non-Current | 1.01B | ||
| Current Assets | 1.81B | ||
| Property, Plant & Equipment Net | 373.80M | ||
| Total Assets | 3.35B | ||
| Debt Current | 6.09M | ||
| Total Debt | 116.30M | ||
| Current Liabilities | 242.08M | ||
| Debt Non-Current | 110.21M | ||
| Total Liabilities | 352.29M | ||
| Accumulated Retained Earnings (Deficit) | -2.48B | ||
| Accumulated Other Comprehensive Income | -6.83M | ||
| Shareholders Equity | 3.00B | ||
| Shareholders Equity (USD) | 3.00B | ||
| Assets Non-Current | 1.53B | ||
| Total Debt (USD) | 116.30M | ||
| Liabilities Non-Current | 110.21M | ||
| Trade and Non-Trade Payables | 63.06M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.85M | ||
| Net Cash Flow from Financing | 601.58M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 86.88M | ||
| Capital Expenditure | -14.79M | ||
| Issuance (Purchase) of Equity Shares | 610.88M | ||
| Net Cash Flow from Investing | -233.41M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -218.62M | ||
| Net Cash Flow from Operations | -280.62M | ||
| Effect of Exchange Rate Changes on Cash | -664.00K | ||
| Share Based Compensation | 37.96M | ||